Elevated baseline C-reactive protein is associated with treatment failure and shorter survival after Yttrium-90 radioembolization in hepatocellular carcinoma.
- DOI
- 10.1007/s12149-026-02287-w
- Published
- 2026 Sep 22
- Container
- Annals of nuclear medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12149-026-02287-w,
title = {Elevated baseline C-reactive protein is associated with treatment failure and shorter survival after Yttrium-90 radioembolization in hepatocellular carcinoma.},
author = {Kaya EM and Esen Akkaş B and Güzelbey T and Erdim Ç and Arslan MF and Şin C and Kapucu HB and Dere AB and Kaya M},
year = {2026},
journal = {Annals of nuclear medicine},
doi = {10.1007/s12149-026-02287-w},
url = {https://doi.org/10.1007/s12149-026-02287-w}
}RIS
TY - JOUR TI - Elevated baseline C-reactive protein is associated with treatment failure and shorter survival after Yttrium-90 radioembolization in hepatocellular carcinoma. AU - Kaya EM AU - Esen Akkaş B AU - Güzelbey T AU - Erdim Ç AU - Arslan MF AU - Şin C AU - Kapucu HB AU - Dere AB AU - Kaya M PY - 2026 JO - Annals of nuclear medicine DO - 10.1007/s12149-026-02287-w UR - https://doi.org/10.1007/s12149-026-02287-w ER -
APA
EM, K., B, E. A., T, G., Ç, E., MF, A., C, Ş., HB, K., AB, D., & M, K. (2026). Elevated baseline C-reactive protein is associated with treatment failure and shorter survival after Yttrium-90 radioembolization in hepatocellular carcinoma.. Annals of nuclear medicine. https://doi.org/10.1007/s12149-026-02287-w
Source records
- pubmed · retrieved 2026-09-25T20:05:47.950Z